1. Home
  2. HALO vs SNV Comparison

HALO vs SNV Comparison

Compare HALO & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • SNV
  • Stock Information
  • Founded
  • HALO 1998
  • SNV 1888
  • Country
  • HALO United States
  • SNV United States
  • Employees
  • HALO N/A
  • SNV N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • SNV Major Banks
  • Sector
  • HALO Health Care
  • SNV Finance
  • Exchange
  • HALO Nasdaq
  • SNV Nasdaq
  • Market Cap
  • HALO 7.4B
  • SNV 6.8B
  • IPO Year
  • HALO N/A
  • SNV N/A
  • Fundamental
  • Price
  • HALO $52.81
  • SNV $48.78
  • Analyst Decision
  • HALO Buy
  • SNV Buy
  • Analyst Count
  • HALO 9
  • SNV 23
  • Target Price
  • HALO $63.56
  • SNV $57.09
  • AVG Volume (30 Days)
  • HALO 1.7M
  • SNV 834.5K
  • Earning Date
  • HALO 08-05-2025
  • SNV 07-16-2025
  • Dividend Yield
  • HALO N/A
  • SNV 3.21%
  • EPS Growth
  • HALO 55.40
  • SNV 21.31
  • EPS
  • HALO 3.76
  • SNV 3.54
  • Revenue
  • HALO $1,084,306,000.00
  • SNV $1,928,671,000.00
  • Revenue This Year
  • HALO $25.77
  • SNV $28.48
  • Revenue Next Year
  • HALO $18.01
  • SNV $5.42
  • P/E Ratio
  • HALO $14.04
  • SNV $13.66
  • Revenue Growth
  • HALO 25.64
  • SNV N/A
  • 52 Week Low
  • HALO $42.01
  • SNV $35.94
  • 52 Week High
  • HALO $70.51
  • SNV $59.92
  • Technical
  • Relative Strength Index (RSI)
  • HALO 41.21
  • SNV 56.07
  • Support Level
  • HALO $53.54
  • SNV $46.95
  • Resistance Level
  • HALO $55.60
  • SNV $49.83
  • Average True Range (ATR)
  • HALO 1.24
  • SNV 1.01
  • MACD
  • HALO 0.09
  • SNV -0.15
  • Stochastic Oscillator
  • HALO 4.62
  • SNV 68.09

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

Share on Social Networks: